Tenaya Therapeutics Inc
TNYA
Company Profile
Business description
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
Contact
171 Oyster Point Boulevard
Suite 500
South San FranciscoCA94080
USAT: +1 650 825-6990
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
97
Stocks News & Analysis
stocks
2 companies poised to capitalize on the rise of GLP-1 drugs
Why Pfizer and Roche look like top choices for investors in the war to tip the scales.
stocks
Does this bank have what it takes to compete with the big 4?
Organic growth and a recent acquisition were the focus of their investor day.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,891.10 | 5.00 | -0.06% |
| CAC 40 | 8,108.43 | 6.31 | -0.08% |
| DAX 40 | 24,046.01 | 17.87 | 0.07% |
| Dow JONES (US) | 47,739.32 | 215.67 | -0.45% |
| FTSE 100 | 9,645.09 | 21.92 | -0.23% |
| HKSE | 25,542.34 | 223.02 | -0.87% |
| NASDAQ | 23,545.90 | 32.22 | -0.14% |
| Nikkei 225 | 50,737.98 | 156.04 | 0.31% |
| NZX 50 Index | 13,429.98 | 56.34 | -0.42% |
| S&P 500 | 6,846.51 | 23.89 | -0.35% |
| S&P/ASX 200 | 8,601.50 | 4.90 | -0.06% |
| SSE Composite Index | 3,918.83 | 5.25 | -0.13% |